智能手表惯性传感器持续监测帕金森病真实世界运动波动
研究开发了基于智能手表惯性传感器的MM4PD系统,在343名帕金森病患者中验证,其中225人纵向随访达6个月。MM4PD测量的震颤严重程度与临床评估相关(ρ=0.80),运动障碍存在与专家评分相关(P<0.001),94%受试者的症状变化与临床预期一致。
要点
- MM4PD通过智能手表惯性传感器连续追踪静息震颤和运动障碍波动。
- MM4PD震颤测量与临床评估相关(ρ=0.80),运动障碍映射专家评分(P<0.001)。
- 94%受试者症状变化与临床预期一致,6%病例数据提示可优化用药策略。
核心结论
- MM4PD可连续监测帕金森病真实世界运动波动,支持患者-临床沟通、药物滴定和临床试验设计。
研究设计与样本
- 开发MM4PD门诊监测系统,使用智能手表惯性传感器连续追踪静息震颤和运动障碍波动。
- 在343名帕金森病患者中设计和验证MM4PD,包括225人队列长达6个月的纵向研究。
主要发现
- MM4PD测量与震颤严重程度临床评估相关(ρ=0.80)。
- MM4PD测量映射运动障碍存在的专家评分(P<0.001)。
- MM4PD捕获的治疗相关症状变化在94%评估受试者中与临床医生预期一致。
- 剩余6%病例中,MM4PD症状数据识别出改善药物治疗策略的机会。
临床怎么用
- MM4PD可作为支持患者-临床医生沟通、药物滴定和临床试验设计的工具。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Longitudinal, remote monitoring of motor symptoms in Parkinson's disease (PD) could enable more precise treatment decisions. We developed the Motor fluctuations Monitor for Parkinson's Disease (MM4PD), an ambulatory monitoring system that used smartwatch inertial sensors to continuously track fluctuations in resting tremor and dyskinesia. We designed and validated MM4PD in 343 participants with PD, including a longitudinal study of up to 6 months in a 225-subject cohort. MM4PD measurements correlated to clinical evaluations of tremor severity (ρ = 0.80) and mapped to expert ratings of dyskinesia presence (P < 0.001) during in-clinic tasks. MM4PD captured symptom changes in response to treatment that matched the clinician's expectations in 94% of evaluated subjects. In the remaining 6% of cases, symptom data from MM4PD identified opportunities to make improvements in pharmacologic strategy. These results demonstrate the promise of MM4PD as a tool to support patient-clinician communication, medication titration, and clinical trial design.
引用
- Powers R, Etezadi-Amoli M, Arnold EM, et al. Smartwatch inertial sensors continuously monitor real-world motor fluctuations in Parkinson's disease. Sci Transl Med. 2021. PMID: 33536284. doi:10.1126/scitranslmed.abd7865
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。